Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-1,333
Closed -$3K 4393
2017
Q3
$3K Sell
1,333
-500
-27% -$1.69K ﹤0.01% 3704
2017
Q2
$7K Buy
1,833
+333
+22% +$1.14K ﹤0.01% 3271
2017
Q1
$4K Hold
1,500
﹤0.01% 3477
2016
Q4
$3K Hold
1,500
﹤0.01% 3600
2016
Q3
$5K Buy
1,500
+167
+13% +$765 ﹤0.01% 3294
2016
Q2
$18K Buy
+1,333
New +$22.2K ﹤0.01% 2427
2016
Q1
Sell
-1,333
Closed -$21K 4363
2015
Q4
$21K Buy
+1,333
New +$22.9K ﹤0.01% 2153

Other funds holding CYTR

IFP Advisors's CYTR Position: Q4 2017 in Review

IFP Advisors sold out of CytRx Corp (CYTR) in Q4 2017, closing a stake of 1,333 shares — an estimated $3K sold.

IFP Advisors first reported a position in CYTR in Q4 2015 and held it in 7 quarters. The position peaked at $21K in Q4 2015. 33 funds tracked by Wall St. Rank hold CYTR as of Q4 2017.

  • IFP Advisors reported no remaining CytRx Corp position as of Q4 2017 after selling out during the quarter.
  • IFP Advisors sold 1,333 CytRx Corp shares in Q4 2017, an estimated $3K.
  • IFP Advisors first reported a position in CytRx Corp in Q4 2015 and held it in 7 quarters.
  • IFP Advisors's CytRx Corp position peaked at $21K in Q4 2015.
  • 33 funds tracked by Wall St. Rank held CytRx Corp as of Q4 2017.

Based on IFP Advisors's 13F filing for Q4 2017, filed 24 Jan 2018.